Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Non-Current Assets (2016 - 2017)

Historic Non-Current Assets for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $170.0.

  • Bone Biologics' Non-Current Assets fell 3971.63% to $170.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $824.0, marking a year-over-year change of. This contributed to the annual value of $242.0 for FY2016, which is N/A changed from last year.
  • Latest data reveals that Bone Biologics reported Non-Current Assets of $170.0 as of Q3 2017, which was down 3971.63% from $194.0 recorded in Q2 2017.
  • Over the past 5 years, Bone Biologics' Non-Current Assets peaked at $362.0 during Q1 2016, and registered a low of $170.0 during Q3 2017.